Bharat Biotech completes trials for India's first intranasal Covid-19 vaccine | Oneindia News*News

Video Credit: Oneindia
Published on August 15, 2022 - Duration: 01:52s

Bharat Biotech completes trials for India's first intranasal Covid-19 vaccine | Oneindia News*News

Today, Bharat Biotech International Limited said that it has completed the clinical development for phase III trials and booster doses for the BBV154 (Covaxin) intranasal Covid-19 vaccine.

#BharatBiotech #IntranasalCovidVaccine #Covaxin bharat biotech,covaxin vaccine bharat biotech,covid vaccine,bharat biotech covaxin phase 3,bharat biotech vaccine,nasal vaccine,bharat biotech nasal vaccine,covaxin bharat biotech,bharat biotech vaccine for coronavirus,phase 3 trial for nasal vaccine almost complete,bharat biotech nasal covid vaccine,covid nasal vaccine bharat biotech,bharat biotech vaccine trialOneindia English, Oneindia News.


You are here


๐Ÿ’ก newsR Knowledge: Other News Mentions



Covaxin

Vaccine against COVID-19

BBV154

Vaccine candidate against COVID-19

Related videos from verified sources

Covid-19 update: India logs 3,947 new cases and 18 deaths in last 24 hours | Oneindia News *News 01:32
Video credit: Oneindia - Published 2 days ago 

Covid-19 cases in India witness slight dip though daily cases rise to 4,272 | Oneindia News *News 01:41
Video credit: Oneindia - Published 3 days ago 

Covid-19 Update: India reports 3,615 fresh Covid-19 cases in 24 hours | OneIndia News *News 02:13
Video credit: Oneindia - Published 4 days ago 

You might like